Specialty Chemicals company Neogen Chemicals announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Revenues stood at Rs 203 crore, reflecting a YoY growth of 2%. EBITDA came in at Rs 36 crore, marking a 2% increase compared to the previous year. Profit Before Tax (PBT) was Rs 18 crore, showing a decline of 21% YoY. Adjusted Profit Before Tax amounted to Rs 4 crore, representing a sharp drop of 84% YoY. Profit After Tax (PAT) stood at Rs 2 crore, down by 86% YoY. FY25 Financial Highlights: Revenues were Rs 778 crore, reflecting a YoY growth of 13%. EBITDA amounted to Rs 136 crore, up by 24% YoY. Profit Before Tax (PBT) was Rs 64 crore, showing an increase of 22% YoY. Adjusted Profit Before Tax stood at Rs 50 crore, marking a decline of 5% YoY. Profit After Tax (PAT) came in at Rs 35 crore, down by 2% YoY. Commenting on the Q4FY25 performance, Haridas Kanani, Chairman & Managing Director, Neogen Chemicals said: "We have closed FY25 on a strong note, achieving 13% revenue growth & 24% improvement in EBITDA. We accomplished this against a difficult & challenging global industry backdrop. This led to weak pricing, despite some pockets of domestic demand resilience. In addition, our Dahej plant was not fully operational towards the end of Q4 due to the fire incident. Our solid performance was a result of our ability to swiftly adapt to a challenging environment by strategically pivoting towards product applications that had favorable demand. Concerning the recent fire incident at our Dahej plant, I would like to reassure all our stakeholders that this is just a temporary setback. With our dedicated team and unwavering resolve, we are confident we will not only overcome the setback but emerge stronger and more efficient. In fact, we have already begun construction of another plant at an adjacent location at the same site which will replace the existing plant. We are making strong progress on the Neogen Ionics' Lithium Salts and Electrolytes project. As several domestic battery manufacturers are set to commence production in FY26, boosting demand for battery materials, we are also on track to commission, by the end of FY26, our greenfield Battery Materials facility, using MUIS technology. While FY25 was a challenging year, the road ahead looks promising. Neogen Chemicals is well poised to leverage its expertise across multiple chemistries to drive sustained growth going forward. In addition to actively focusing on higher-value specialty chemicals, significant contribution from upcoming lithium-ion battery materials segment will further diversify our revenue streams and accelerate our growth trajectory.” Result PDF
Specialty Chemicals company Neogen Chemicals announced Q3FY25 results Revenues: Rs . 201.4 crore during Q3FY25, change 22% YoY. EBITDA: Rs 34.6 crore during Q3FY25, change 71% YoY. PBT: Rs 15.3 crore during Q3FY25, change 263% YoY. PAT: Rs 10 crore during Q3FY25, change 844% YoY. Haridas Kanani, Chairman & Managing Director, Neogen Chemicals, said: “Our Q3FY25 results demonstrate a robust recovery, with revenue up 22% and EBITDA up 71%. This growth is attributed to strong ramp-up in BuLi Chem and sustained growth in the base business volumes. Higher topline was achieved despite lower RM prices and resultant realizations acrossseveral product categories. New product launches and the pursuit of export opportunities drove the robust recovery. To mitigate the persistent slowdown in agrochemicals, we have strategically created additional end-use sectors such as semiconductors, flavors & fragrances and select industrial CSM opportunities. This highlights the adaptability of our agile business model, enabling us to meet evolving market needs and capitalize on emerging opportunities. Neogen Ionics is rapidly advancing its Lithium Salts and Electrolyte projects. A major ACC battery manufacturer has already started trial production plant in India, with several others preparing to do so within the next two years. This will drive their demand for local procurement of both Electrolyte and Lithium Salt. Meanwhile, we are supplying products from our initial capacity to potential manufacturers, aiming to establish long-term customer partnerships. We are on schedule to commission our greenfield Battery Materials facility in the second half of FY26. This facility, using MUIS technology, is taking shape with majority of erection and engineering works now complete. The modular construction process is proceeding with equipment assembly and installation. Overall, we are confident of achieving FY26 revenue guidance of Rs 950-1,000 crore in the standalone business. Beyond FY26, the rapid scale up in Neogen Ionics will drive consolidated performance. We maintain a long-term growth strategy, undeterred by short-term setbacks. Neogen Chemicals remains committed to capitalizing on emerging opportunities to generate sustained value for all stakeholders.” Result PDF
Specialty Chemicals company Neogen Chemicals announced Q2FY25 results In Q2FY25, revenue was higher by 20% to Rs 193 crore fueled by increased volumes in the core business, coupled with incremental contribution from BuLi Chem. EBITDA stood at Rs 35 crore, an increase of 33% YoY. Profit after Tax (PAT) grew by 38% to Rs 11 crore. Earnings per share (EPS) for Q2FY25 stood at Rs 4.15 per share (Rs. 3.17 per share in Q2FY24). Haridas Kanani, Chairman & Managing Director, Neogen Chemicals, said: “We have delivered a strong performance during the period under review amid a challenging backdrop of events marked by soft demand, oversupply situation, geopolitical tensions and inflationary pressures, which have eroded industry’s pricing power and profitability. Our 20% revenue improvement and 38% PAT growth in Q2FY25 is a testament to our team's unwavering dedication, adaptability, and ability to navigate challenging market conditions. Volume gains in the base business as well as contributions from BuLi Chem and Neogen Ionics fostered consolidated performance. Through Neogen Ionics, we are making deep inroads in the Battery Materials business. Through our collaborative efforts, we have developed and exchanged multiple recipes of Electrolyte & Lithium Salt combinations with our customers. While doing so, we have gained valuable insightsinto the technological capabilities and market expertise. Our pilot production lines are currently manufacturing and shipping commercial trial lots, while the initial commercial production facilities are operational and fulfilling early market demand. Stringent quality standards are being maintained through strict adherence to safety protocols. The construction of our dedicated greenfield Battery Materials plant in Dahej using MUIS technology license is advancing steadily & remains on expected timelines. We are strategically phasing the commissioning process aligning with Battery capacities coming in India. While we anticipate a potential demand recovery later in FY25, we are committed to investing in our long-term growth strategy to secure our future. In the face of global economic uncertainty, we at Neogen Chemicals are adapting to changing conditions, and remain steadfast in our commitment to growth, innovation, and delivering value to ourstakeholders.” Result PDF
Conference Call with Neogen Chemicals Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.